Navigation Links
Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
Date:7/30/2013

(PRWEB) July 30, 2013

As progress continues in the Pradaxa multi district litigation (MDL), the bellwether case selection process has concluded with one of Doyle Raizner’s cases being chosen. Doyle Raizner’s case is one of 16 cases out of approximately 871 currently pending cases that were selected to move into the bellwether case-specific discovery phase. After the conclusion of case-specific discovery, Presiding Judge David Herndon will select four of the 16 cases to proceed to trial on August 11, 2014, November 3, 2014, January 5, 2015, and February 16, 2015. Judge Herndon’s selection of the four trial cases will occur on or before November 22, 2013.

Bellwether case selection is a judicial procedure where a select group of cases are presented for determining core issues, such as liability and damages, for the remaining cases. The outcome of the bellwether trials typically assists in the resolution of all cases within multi-district litigation. They also assist in expediting the trial process. In the case of Pradaxa litigation Judge Herndon promised an expedited process due to the age of the plaintiffs, among other factors.

“The patient whose case was selected for the bellwether selection suffered a near fatal episode of gastrointestinal bleeding just two weeks after her initial dose of Pradaxa,” said Patrick Dennis, the Doyle Raizner partner who manages the firm’s pharmaceutical docket.

Pradaxa litigation was consolidated into a MDL in August 2012 in the Southern District of Illinois, a federal court. [Docket No. 3:13-cv-50028-DRH-SCW] The court will handle claims that the blood thinner, Pradaxa, has serious and often deadly adverse side effects, including an increased risk of gastrointestinal and other bleeds, which were not properly communicated by Boehringer Ingelheim to healthcare professionals or patients. The drug is often prescribed to elderly patients to reduce the risk of stroke in people with atrial fibrillation. Compounding, a possible internal bleeding risk is the lack of an antidote to stop Pradaxa’s internal bleeding side effect. No antidote exists because Pradaxa was rushed to market before Boehringer Ingelheim took efforts to develop an antidote to protect patients taking this drug. As a result, many takers of Pradaxa have suffered from hemorrhages and deaths. The large number of complaints and impending personal injury cases against Pradaxa moved it to the top of 2011’s most dangerous drug report issued by the Institute for Safe Medication Practices, January 12, 2012.

To learn more about the firm and their part in Pradaxa litigation, please visit http://www.PradaxaLitigation.com.

About Doyle Raizner LLP:

Doyle Raizner LLP is a national personal injury litigation firm with main offices in Houston, Texas and Phoenix, Arizona. The firm's attorneys specialize in helping victims’ secure fair compensation for injuries or the death of a loved one.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10937550.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
2. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
3. Pradaxa Lawsuit Attorneys at Wright & Schulte LLC Report on Scheduling of Bellwether Trials in Federal Pradaxa Bleeding Lawsuits
4. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking Pradaxa to Increased Heart Attack Risk
5. New Lawsuit on Pradaxa Bleeding: Now, AttorneyOne Can Provide Advice
6. New Study Casts Doubt on FDA Pradaxa Conclusions
7. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Side Effects Litigation
8. Pradaxa Lawsuit News: Bernstein Liebhard LLP Notes Pradaxa Bleeding Claims Pending in Federal Litigation Now Exceed 1,000
9. Latest Pradaxa Internal Bleeding Problem Allegation Lawsuits Update; Resource4thePeople Reports Judge Schedules Important Hearing
10. New Lawsuit on Alleged Pradaxa Wrongful Death: Now, AttorneyOne Can Provide Advice
11. Pradaxa Lawsuits Move Ahead As Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: